× Current Issue Archive Submit Article
Conflicts of Interest Copyright and Access Open access policy Editorial Policies Peer Review Policy Privacy Statement Publishing Ethics
Editor in chief Associate Editors Advisory Board International Editors
Contact Us About Us Aim & Scope Abstracting And Indexing Author Guidelines Join As Editor

Analytical method development & validation of Eperisone Hydrochloride and Diclofenac Sodium in Rapisone D SR Capsules by RP-HPLC


Alagar Raja. M, Godavari Swetha, David Banji, Selva Kumar.D, Vanitha .C

Abstract

A simple, sensitive, rapid, accurate, precise and reproducible Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method was developed for the simultaneous quantitative determination of Diclofenac Sodium(DIC) & Eperisone Hydrochloride (EPE) in capsule dosage form and statistically validated as per ICH guidelines. The Chromatographic separation was carried out on a Thermo Hypersil C-8 column (250×4.6mm, 5μm) by gradient elution mode. The mobile phase consists of Methanol, Phosphate Buffer(0.1M, pH 6) and Acetonitrile in the ratio of 30:40:30 (v/v/v) pumped at a flow-rate of 1.0 mL/min. The PDA detector was employed at a wavelength of 261nm. The retention times of Diclofenac Sodium & Eperisone Hydrochloride were found to be 2.21 min and 3.6 min respectively. The calibration curves were linear in the range of 20- 80μg/mL & 30-120 μg/mL for DIC & EPE. The method is accurate with %w/w recoveries of 99.03% & 100.9 % for Diclofenac Sodium and Eperisone Hydrochloride respectively & the method is precise with % RSD < 2.The proposed method is rapid, simple and does not require any separation process and it has been successfully applied to the assay of pharmaceutical dosage form(RAPISONE D SR capsules).




Contact Meral


Meral Publications
www.meralpublisher.com

Davutpasa / Zeytinburnu 34087
Istanbul
Turkey

Email: [email protected]
Tell: +905344998991